Acura Pharmaceuticals, Inc. filed its 10-K on Jun 30, 2023 for the period ending Dec 31, 2021. In this report its auditor, , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0041 USD | +36.67% | -59.00% | +4,000.00% |
1st Jan change | Capi. | |
---|---|---|
+4,000.00% | 272K | |
+10.44% | 107B | |
+0.82% | 106B | |
+8.88% | 23.47B | |
-13.89% | 21.9B | |
-5.99% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- ACUR Stock
- News Acura Pharmaceuticals, Inc.
- Acura Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt